Literature DB >> 24980228

The pathophysiology of sinonasal conditions and novel therapeutic options.

Anju T Peters.   

Abstract

Mesh：

Year:  2014        PMID： 24980228      PMCID： PMC4374136          DOI： 10.2500/ajra.2014.28.4070

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN： 1945-8932            Impact factor:   2.467


× No keyword cloud information.
  20 in total

1.  Chronic cholesterol depletion by lovastatin suppresses MUC5AC gene expression in human airway epithelial cells.

Authors:  Eun Jung Lee; Kee Jae Song; Jin Ho Kwon; Ah Young Park; Kwang-Hee Jo; Kyung-Su Kim
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

2.  Efficacy of inferior turbinoplasty with the use of CO(2) laser, radiofrequency, and electrocautery.

Authors:  Emmanuel P Prokopakis; Eleftherios I Koudounarakis; George A Velegrakis
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

3.  Neonatal vaccination with plasmid DNA encoding Cyn d 1 effectively prevents allergic responses in mice.

Authors:  Ching-Feng Huang; Chia-Chao Wu; Der-Ming Chu; Zo-Nan Chang; Fung-Lin Chue; Ho-Jen Peng
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

4.  Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules.

Authors:  Se Jin Park; Young Joon Jun; Ki Jeong Lee; Soo Min Hwang; Tae Hoon Kim; Seung Hoon Lee; Sang Hag Lee
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

5.  Histamine type 2 receptor expression on peripheral blood regulatory lymphocytes in patients with allergic rhinitis treated with specific immunotherapy.

Authors:  Maciej Ciebiada; Karolina Kasztalska; Malgorzata Gorska-Ciebiada; Paweł Górski
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

6.  Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps.

Authors:  Thibaut Van Zele; Gabriele Holtappels; Philippe Gevaert; Claus Bachert
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

7.  Expression of apoptosis mediators p53 and caspase 3, 7, and 9 in chronic rhinosinusitis with nasal polyposis.

Authors:  Daniel Salgado Küpper; Fabiana C P Valera; Rafael Malinsky; Cristiane Maria Milanezi; João S Silva; Edwin Tamashiro; Wilma T Anselmo-Lima
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

8.  Allergen-specific immunotherapy increases plasma gelsolin levels.

Authors:  Sabina Janciauskiene; Beata Olejnicka; Rembert Koczulla; Lars-Olaf Cardell; Tobias Welte; Ulla Westin
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

9.  Comparison of topical anesthetic effects of lidocaine, prilocaine, ropivacaine, and bupivacaine in transnasal fiberoptic nasopharyngolaryngoscopy.

Authors:  Mahmut Özkiriş; Reha Aydin; Zeliha Kapusuz Gencer; Levent Saydam
Journal:  Am J Rhinol Allergy       Date:  2014 May-Jun       Impact factor: 2.467

10.  A double-blind randomized controlled trial of normal saline, lactated Ringer's, and hypertonic saline nasal irrigation solution after endoscopic sinus surgery.

Authors:  Tsu-Hui Hubert Low; Charmaine M Woods; Shahid Ullah; A Simon Carney
Journal:  Am J Rhinol Allergy       Date:  2014-01-16       Impact factor: 2.467
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.